Results 261 to 270 of about 1,818,147 (330)
Glatiramer Acetate Reduces Risk of Cardiovascular Disease and Myocardial Infarction. [PDF]
Lehrer S, Rheinstein PH.
europepmc +1 more source
Cardiovascular disease and adult healing cells: From bench top to bedside [PDF]
Black Jr., Asa C+8 more
core +1 more source
Objective Our objective was to assess the incidence of major adverse cardiovascular events (MACEs) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), or biologic disease‐modifying antirheumatic drugs with other modes of action (bDMARD‐OMA) in a multicountry, real‐world population ...
Romain Aymon+28 more
wiley +1 more source
Early initiation of SGLT2 inhibitors after acute myocardial infarction. [PDF]
Hammer A, Sossalla S, Sulzgruber P.
europepmc +1 more source
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
S. Agewall+13 more
semanticscholar +1 more source
ABSTRACT Since cholesterol triggers many diseases, many methods have been developed for its determination. In this study, an alternative system for cholesterol determination was developed by preparing amperometric biosensors. In the development of the biosensor, Pt/polypyrrole–polystyrene sulfonate film was prepared by electropolymerization of ...
Alaa Anwer Ali Dada+3 more
wiley +1 more source
Plant-derived hydrogel and photosynthetic nano-units for myocardial infarction therapy. [PDF]
Lv Y+11 more
europepmc +1 more source
Aims Several methods exist to identify hospital admissions related to adverse drug events (ADEs). Clinical adjudication by healthcare professionals is the gold standard but is labour‐intensive. Spontaneous reporting and routinely collected healthcare data using a set of International Classification of Diseases (ICD) codes often underestimate the ...
Zuzana Juhásová+2 more
wiley +1 more source